BIO Investor Forum 2012 Participating Companies

  • Recommend
  • Tweet
  • Print
  • Email
5AM Ventures
Abbott Biotech Ventures
Abingworth Management, Inc.
Accelerator Corporation
Access BridgeGap Ventures
Acetylon Pharmaceuticals, Inc.
Addex Therapeutics
Advaxis
Advent Healthcare Ventures
ADVENTRX Pharmaceuticals, Inc
Affimed Therapeutics AG
Aisling Capital
Alfidi Capital
Allon Therapeutics Inc.
Alta Partners
Altheus Therapeutics, Inc.
Alzheimer's Association
Ambit Biosciences Corporation
Amgen
Angel Capital Association, Life Science Angels
Apjohn Ventures
Applied Microarrays, Inc.
Apposite Capital
Aquilo Capital
Arcion Therapeutics Inc
Arrogene
Ascendiant Capital Partners
Asmacure Ltd
Astellas Venture Management LLC
Astex Pharmaceuticals, Inc.
ATEL Ventures
Atox Bio
Avelas Biosciences
Bailard Investments
Baxter Healthcare
Baxter Ventures
Bay Biotech Consulting
Bay City Capital
BayBio
BB Biotech Ventures
Benitec Biopharma
BioCentury Publications
biocrea
BioCycive
Bio-Path Holdings, Inc.
BioSante Pharmaceuticals, Inc
Biotech Insight
BioWorld Insight
bluebird bio
Breakout Labs, Thiel Foundation
Broadvector Limited
Burrage Capital
Burrill & Company
BVF LP
BWS Financial Inc.
Campbell Alliance
Cancer Prevention and Cure, Ltd.
Capital Midwest
Capital Royalty L.P.
Cato BioVentures
CDIB Bioscience Ventures
Cell Therapeutics, Inc
Cellular Engineering Technologies, Inc.
Celtaxsys, Inc.
Center for Venture Education
Ceregene, Inc
Charter Life Sciences
Chimerix, Inc.
CHL Medical Partners, L.P.
Clarus Ventures
CLS Capital
CMEA Capital
Cognition Therapeutics
Collegium Pharmaceutical, Inc.
CoLucid Pharmaceuticals, Inc
Complexa
ContraFect Corporation
Coyote Pharmaceuticals
Credit Suisse
Cyclacel Pharmaceuticals
Cylene Pharmaceuticals, Inc
CytRx Corporation
Dalton Pharma Services
Danken Ventures
DBL Investors
Déclion Pharmaceuticals
DFJ Mercury
Dicerna Pharmaceuticals, Inc
Durata Therapeutics, Inc.
EGB Advisors, LLC
Elanco
Epizyme, Inc.
Eqalix
Eureka! Biosciences
F.Hoffmann-La Roche AG
Forbes & TheStreet
Forma Therapeutics, Inc.
Franklin Templeton Investments
Frazier Healthcare Ventures
Fred Hutchinson Cancer Research Center
FreeMind Group, LLC
Galena Biopharma
Galleon Pharmaceuticals, Inc
GenVec, Inc
GeoVax Labs, Inc
GlaxoSmithKline
GlycoMimetics, Inc
HeatFlow Technologies, Inc.
Helix Ventures, LLC
Hermo Pharma Ltd.
HMAS, Inc.
Hold Capital
Horizon Pharma, Inc
Ignyta
immatics biotechnologies GmbH
Immune Design Corporation
Immune Targeting Systems (ITS ) Ltd
ImmunoCellular Therapeutics, Ltd
Immunome, Inc.
Immunomic Therapeutics, Inc
Immunomix
Immunovaccine Inc.
Inception Sciences, Inc.
Index Ventures
Infinity Venture Group
Ingenuity Ventures
InnoBioscience
inovation ventures
Inspirotec, LLC
InterWest Partners
Intrexon
Inven2
JAFCO Life Science Investment
Janssen
JJX Associates
JMJ Financial
Johnson & Johnson Development Corporation
JT Pharma
Karolinska Development AB
Kearny Venture Partners
KemPharm, Inc
KineMed
Knobbe Martens
La Jolla Cove Investors
Leader Ventures
Leukemia & Lymphoma Society
Life Science Leader
Lincoln Park Capital
Lipocine Inc
Lonestar Heart, Inc
Longitude Capital
MabVax Therapeutics, Inc.
Maxygen, Inc
Medical Technology Stock Letter
MedImmune Ventures, Inc.
MEI Pharma
Merck
Metabolex, Inc
Metabolon, Inc.
Midatech Group
Midcap Financial LLC
Mission Bay Capital
Modulation Therapeutics
Morgenthaler Ventures
MP Healthcare Venture Management, Inc.
MPM Capital
Muse Capital
Mustang Ventures
Myelin Repair Foundation
MyeloRx LLC
Myriad Genetics
Nature Biotechnology
New Leaf Venture Partners, LLC
NexBio
Norwest Venture Partners
Novartis Option Fund
Novelos Therapeutics, Inc.
NOXXON Pharma AG
NTpharma LLC
Numoda Capital Innovations
Odin
OHR Pharmaceutical
Omniox, Inc
OncoMed Pharmaceuticals, Inc.
OrbiMed Advisors
Organovo, Inc.
Oxford Finance LLC
Pac-Link Bioventures
PAI
Panorama Capital
Partnership For Clean Competition
Patrick Associates
Pfizer
Profil Institute for Clinical Research, Inc.
Profil Institute for Translational Medicine
Promedior, Inc
Prosensa Therapeutics
Protaffin Biotechnologie Ag
Protagonist Therapeutics, Inc
Proteostasis Therapeutics Inc.
Purdue Pharma LP
Quintiles, Inc.
Real Endpoints
Regenesance BV
Residence Nob Hill Properties and Investments
Resverlogix Corporation
Retrophin
RHS Financial
Rib-X Pharmaceuticals, Inc.
Rodman & Renshaw
RRC Bio Fund
Sage Therapeutics
SB Life Science
Scholar Rock, LLC
Science Futures LLC
Senesco Technologies, Inc
Serina Therapeutics, Inc.
Shire Pharmaceuticals
Skyline Ventures
Sofinnova Ventures
Sophiris Bio, Corp
Spectrum Pharmaceuticals, Inc
SR One
Stafford Capital Management
Stanford University School of Medicine
Stansberry Research
Start-Up / In Vivo
STATegics, Inc.
Stemline Therapeutics
Stifel Nicolaus Weisel
Susavion Biosciences, Inc
Sutro Biopharma, Inc
SVB Capital
Symbio Pharmaceuticals Limited
Symmetry Capital
Syzygy Therapeutics
Takeda Pacific Hightech Reports
Takeda Ventures, Inc.
Tavistock
Tempero Pharmaceuticals
Terapio Corporation
Tetraphase Pharmaceuticals, Inc
The Burrill Report
The Glynn Group
The Leukemia & Lymphoma  Society
The Life Sciences Report
The Scripps Research Institute
Theraclone Sciences, Inc
TheraVida, Inc
Third Rock Ventures
Third Security, LLC
Thomas, McNerney & Partners
Threshold Pharmaceuticals, Inc
TissueGene, Inc
TPG Biotech
Transposagen Biopharmaceuticals, Inc
Tranzyme Pharma
Trellis Bioscience, Inc
Trevena, Inc.
triplepoint capital
Tunitas Therapeutics
Ultragenyx Pharmaceutical Inc.
UCSD
University of California, San Francisco
Vaccinogen, Inc.
VantagePoint Capital Partners
Velocity Pharmaceutical Development
venBio LLC
Venrock
Ventures West Capital Ltd.
Verastem
Versant Ventures
Vista Capital Investments, LLC
Vista Partners LLC
Vivo Ventures
VLST Corporation
Warburg Pincus
Wedbush Securities
Wellesley Pharmaceuticals
WIRED Magazine
Xalud Therapeutics
Yasuda Enterprise Development Co., Ltd.
Zafgen
ZIOPHARM Oncology, Inc
Zosano Pharmaceutical, Inc
Zymeworks Inc 
 
As of 10/5/2012